3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Glioblastoma
202
Central Nervous System Neoplasms
122
Brain Neoplasms
107
Gliosarcoma
85
Glioma
68
Astrocytoma
63
Oligodendroglioma
34
Neuroblastoma
29
Medulloblastoma
20
Neoplasm Metastasis
19
Carcinoma, Non-Small-Cell Lung
15
Lung Neoplasms
14
Ependymoma
11
Diffuse Intrinsic Pontine Glioma
11
Breast Neoplasms
11
Meningeal Carcinomatosis
8
Neoplasms
7
Lymphoma
7
Squamous Cell Carcinoma of Head and Neck
6
Sarcoma
6
Optic Nerve Glioma
6
Neuroectodermal Tumors, Primitive
6
Lymphoma, Follicular
6
Head and Neck Neoplasms
6
Esthesioneuroblastoma, Olfactory
6
Burkitt Lymphoma
6
Spinal Cord Neoplasms
5
Salivary Gland Neoplasms
5
Rhabdoid Tumor
5
Recurrence
5
Interventions
Temozolomide
2
Oncolytic Virotherapy
2
vorasidenib
1
pembrolizumab
1
pamiparib
1
interferon gamma-1b
1
cixutumumab
1
Vorinostat
1
Vincristine
1
Valproic Acid
1
Thiotepa
1
Radiotherapy
1
Radiation
1
Peripheral Blood Stem Cell Transplantation
1
ONC206
1
Melphalan
1
Maintenance Chemotherapy
1
Lomustine
1
Interleukin-12
1
Interferon-gamma
1
Immunotherapy
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Etoposide
1
Erlotinib Hydrochloride
1
Cisplatin
1
Busulfan
1
Bone Marrow Transplantation
1
Antibodies, Monoclonal
1
Aminolevulinic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Neuroectodermal Tumors
×
Radiotherapy
×
CNS
×
Clear all
NCT01614132
2020-03-31
NOA-07
University of Regensburg
Phase 1/2
Completed
33 enrolled